Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My granddaughter??? LOL
I agree and it is serious. Very good strategy indeed.
LOL Ok thanks Cosa, but don't do anything different for me, just be.
Hi, yes I remember you from those ERHE days. Yes I am aware of those others, but when I heard that Cathie Wood added more, that was all I needed to know. Yes I do have some Bitcoin through my PayPal account too, but as I said Cathie got me in.
Good to see you are here as well.
Thanks and yes she is.
Bought in and no one is here. LOL
Why I just got in: I do own some Bitcoin through my PayPal account and in 1 month gained 40%. But I am not sure if many here are aware of Cathie Wood and her amazing ARK ETF's? She has about 5 of them that all gained over 100% last year, and she just recently added more GBTC to a few of her ETF's. Her funds are very actively managed with much research put in before buying. So if it is good enough for her I figured I am in with some shares in addition to my PayPal account. Not a lot of percentage in my portfolio overall, but I am in.
If I may make a comment to the board as I only became aware of it since I got in?
To me this board has the "feel" of a "pump and dump" board instead of what should be a serious discussion board about GBTC.
Just my 2 cents worth guys and girls. I am 73 years old and maybe my 2 cents is not worth much or maybe it will be ignored, but there you have it.
I do not let over hyped up posts get me excited as I kind of like facts like the fact I gave about Cathie Wood and her investment into this. That excites me much more than a lot of #$$**##@ thrown in a post.
But good luck to all,
Ray
Yeah I will never forget his antics when Nettles had that amazing day in the field. LOL
But yes RIP. A great baseball man and a great man.
Stay well my friend.
BTSC: Bitcoin good entry point? .06 Bitcoin Services.
Hi all. I am in at .00836
Yes 32 years.
Good luck with Dodgers
LUMN: Multiple bottom/10% dividends/partnering with ZOOM
Lumen Technologies (NYSE: LUMN) is the old CenturyLink
Zoom Video Communications Reports Partnership With Lumen, Will Deliver Enhanced Collaboration Experience
9:01 am ET September 29, 2020 (Benzinga)
Zoom Video Communications, Inc. (NASDAQ:ZM) and Lumen Technologies, Inc. (NYSE:LUMN) announced today that the companies will partner allowing Lumen to offer Zoom as part of its Unified Communications and Collaboration Suite. Lumen will deliver enhanced services around Zoom’s best-in-class video-first unified communications platform to their large and growing base of customers across the globe.
Zoom and Lumen will partner to provide enhanced delivery, customer success, and managed services to companies using Zoom, to deliver an outstanding enterprise experience throughout the customer lifecycle. Additionally, the Lumen network will allow it to deliver an enhanced quality experience, as well as combining its embedded network security with Zoom’s built-in security features to proactively protect customers using the combined services.
“Lumen has been helping Zoom deliver amazing experiences and bring happiness to millions of users worldwide with our platform for cloud-connected infrastructure. Unified communications have become more important than ever to businesses, and we are excited to announce this strategic partnership,” said Shaun Andrews, chief marketing officer at Lumen.
“Partnering with Zoom means we can offer our worldwide customers an industry leading edge enterprise video communications platform, and also provide Lumen’s highly connected global network infrastructure and white glove global service wrappers. This is a terrific addition to our Unified Communications portfolio that squarely addresses a growing demand in the Unified Communications space,” said Craig Richter, senior director of product management at Lumen.
“We’re excited to partner with Lumen to ensure wider availability of our platform,” said Ryan Azus, chief revenue officer at Zoom. “Customers expect that Zoom will be ready and working when they need it.”
$1.28 now. The news is good.
Ok thanks
Yes agree
Agree little downside.
$34 is a nice entry point IMO.
Ok well you have time my friend so take your time. You'll need about 1/2 of a million to get $4,000 monthly at 10% roughly.
Again Good luck.
It goes up or down LESS than the markets usually, but it has the dividends. Again I have been in it for over 2 years. It makes money from the volatility of the market through covered call options. Interesting concept I thought.
IF you'd like 2 others that are similar that I also own:
DIVO and HSPX.
HSPX is also options based on the S&P 500 and DIVO uses the option covered call occasionally as a strategy, but is diversified more.
Another that I do NOT yet own is only a year old is RYLD: the Russell index options based ETF.
Do your own DD on DIVO and HSPX even though I own them don't take my word. RYLD I am keeping an eye on.
I own only 6 ETFs and my goal is INCOME, INCOME, INCOME as my wife and I are 73 years old. I only day trade some stocks now, but I used to only be in stocks.
GOOD LUCK.
12:28 pm ET *Morderna shares are trading lower. Weakness potentially related to Axios report indicating the NIH may own certain intellectual property that undergirds the company's vaccine candidate.
Benzinga
Yes little $ to be made in Vaccine, but lives saved.
But I only posted that article, it wasn't my words.
Good luck
Hit $58.50. Support at $50 should hold if it gets there? IMO
Good luck all.
Yes it seems that way.
Why the drop: "HSBC says the results suggest mRNA-based vaccines may not be as immunogenic as hoped."
Covid-19 MRNA Vaccines Face Doubts After Cancer Setback -- Market Talk 10:25 am ET June 25, 2020 (Dow Jones)
Downbeat results from tests of a cancer vaccine based on an unproven technology cast doubt over the chances of using that approach to develop coronavirus vaccines, says HSBC. The bank says data from trials of BNT-122, which uses mRNA technology and was developed by BioNTech and partner Roche Holding, showed what HSBC described as 'clearly disappointing' patient responses. HSBC says the results suggest mRNA-based vaccines may not be as immunogenic as hoped. BioNTech and partner Pfizer, as well as Moderna Inc., are developing Covid-19 vaccines based on mRNA approaches. "The failure of BNT-122 should provide pause for thought on the prospects for mRNA approaches in vaccination for COVID-19 and other diseases," HSBC analyst Steve McGarry says. (philip.waller@wsj.com)
(END) Dow Jones Newswires
June 25, 2020 10:25 ET (14:25 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
"But, a binary play like IBIO may be a better than a more diversified one like Moderna (MRNA).
Moderna shares would bounce back if their vaccine shows success. But the potential rise in its stock price, percentage-wise, likely isn’t as great as you’d see with an IBIO."
https://finance.yahoo.com/news/party-over-moderna-stock-holders-041500337.html
"But, a binary play like IBIO may be a better than a more diversified one like Moderna (MRNA).
Moderna shares would bounce back if their vaccine shows success. But the potential rise in its stock price, percentage-wise, likely isn’t as great as you’d see with an IBIO."
https://finance.yahoo.com/news/party-over-moderna-stock-holders-041500337.html
IBIO picked over MRNA. https://finance.yahoo.com/news/party-over-moderna-stock-holders-041500337.html
I saw IBIO picked over MRNA. I am checking this out. Vaccine ready soon? https://finance.yahoo.com/news/party-over-moderna-stock-holders-041500337.html
IBIO Anyone in this? Vaccine ready soon?
Picked over MRNA.
https://finance.yahoo.com/news/party-over-moderna-stock-holders-041500337.html
BUY CEMI WHY? - Covid-19 testing revoked by FDA. BUT a 60% drop?? It had FDA "emergency use authorization", but never earned any money from it. So NOTHING LOST. The company has other products and more coming. It has been around for 35 years. I used to own a dental lab down the road from it from 1985-1995. They are the SAME company as BEFORE the FDA authorization in April and the share price was $4-6 then with a $9 price target.
This is way over reaction IMO. The 5 year support is $4.
And it is $3.90 now.
So IMO it is a screaming BUY for at LEAST a 25%-50% gain short term.
Do your own DD.
You are welcome.
I just emailed the company as I owned a dental lab down the road from the Chembio lab. They know of me as I was in contact with them in April. So hoping to hear back regarding this latest development. I will post if and when I hear back.
When did they report EARNINGS from tests? NEVER that I know of. So nothing LOST. Back to square 1 and maybe $6. as it WAS.
At LEAST $4. as it has LONG term support at that price. Just look at the charts.
JMHO
Good luck all.
Yes target was $12 recently and before that it was about $20.
So this doesn't change company prior to authorization. It was $4-6 in late March and early April before FDA authorization.
I mean YES it deserves to get killed but not by 60%. IMO
https://www.tipranks.com/stocks/cemi/price-target
5 year support at $4. March 23rd $4. Long term charts though do show strong support at $4.
Cool. Thanks
This was $6 on APRIL 1st BEFORE FDA authorization. No money lost as they didn't make any. The price target was $9.00 then and should still be now.
$4-6 makes sense, company is the SAME as before authorization. They did not lose MONEY from it. They never made any.